ARCHIVES

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

This article is from The Cancer Letter archive.

Vol. 13 No. 19 | May 8, 1987

Download PDF Visit The Full Archive

Related Articles

Cancer Atlast Offers New Research Leads

July 17, 1987

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993

Two Trials Presented at ASCO Demonstrate Drop in Death Risk, Increased Survival

June 24, 2011

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

May 27, 2005

National Dialogue On Cancer, The Cancer Act, And Activism.

February 4, 2000

NCI-Approved Protocols Listed

March 28, 2003